Cutler Group LP Ptc Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$25.6 - $45.23 $7,680 - $13,568	-300 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$33.33 - $44.6 $9,999 - $13,380	300 New	300 $0
Q2 2019 Aug 09, 2019	SELL	$35.42 - $45.0 $38,962 - $49,500	-1,100 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$28.09 - $39.49 $14,045 - $19,745	-500 Reduced 31.25%	1,100 $2,000
Q3 2018 Nov 07, 2018	SELL	$33.9 - $47.77 $200,010 - $281,843	-5,900 Reduced 78.67%	1,600 $5,000
Q2 2018 Aug 10, 2018	BUY	$25.7 - $47.88 $64,250 - $119,700	2,500 Added 50.0%	7,500 $15,000
Q1 2018 May 11, 2018	SELL	$17.46 - $32.59 $426,024 - $795,196	-24,400 Reduced 82.99%	5,000 $11,000
Q4 2017 Jan 17, 2018	SELL	$15.14 - $20.89 $183,194 - $252,769	-12,100 Reduced 29.16%	29,400 $25,000
Q3 2017 Oct 17, 2017	BUY	$16.81 - $21.61 $697,615 - $896,815	41,500	41,500 $156,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.